Contract notice
Section I: Contracting
authority
I.1) Name and addresses
Cell and Gene Therapy Catapult
12th Floor, Guy's Tower, Great Maze Pond
London
SE1 9RT
UK
E-mail: MCProcurement@ct.catapult.org.uk
NUTS: UKI1
Internet address(es)
Main address: https://ct.catapult.org.uk/
I.3) Communication
Access to the procurement documents is restricted. Further information can be obtained at:
https://ct.catapult.org.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent to the abovementioned address
I.4) Type of the contracting authority
Other: partially funded through another contracting authority
I.5) Main activity
Other: cell and gene therapies
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
The Supply and Implementation of a Warehouse Management System.
Reference number: CON-0082
II.1.2) Main CPV code
48000000
II.1.3) Type of contract
Services
II.1.4) Short description
This procurement is for the supply, implementation and support of a Warehouse Management System (WMS) for CGTC. The WMS solution will cover 2 sites, primarily the CGTC Manufacturing Centre in Stevenage with a subset of system functionality available for use at CGTC's Guys Hospital location. The system is to be supplied and implemented to CGTC's requirements by May 2017 in time for the opening of the Manufacturing Centre in July 2017. Completion of formal GMP system qualification would be required to be completed no later than November 2017 in anticipation of inspection for licensure in December 2017.
II.1.5) Estimated total value
Value excluding VAT:
450 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UKH23
Main site or place of performance:
Stevenage.
II.2.4) Description of the procurement
Cell and Gene Therapy Catapult (CGTC) is part of a world-leading network of technology and innovation centres, established in December 2012 and now with over 100 employees, we believe through science and industry, our expertise in cell and gene therapies will one day provide better treatments that will help improve patient quality of life whilst building a global industry the UK can be proud of. Our mission to deliver health and wealth is supported by the UK's enviable academic base. We strive to be a world leader in cell and gene therapy and support those who wish to convert research into products that have the potential to have direct impact in advanced healthcare.
CGTC is not alone in this ambition. Regenerative medicine is one of the government's eight great technologies that support UK science strengths and capabilities.
CGTC's offices are located in Guys Hospital in London. CGTC are building a 55 000 000 GBP large-scale GMP Manufacturing Centre to help bring cell and gene therapies to market in the UK and internationally. It will provide the UK with the manufacturing facilities needed for later-stage cell and gene therapy clinical studies and commercialisation. The centre benefits from an established supply chain, prime UK location in Stevenage and expert impartial advice from the Cell and Gene Therapy Catapult, enabling the manufacture of therapies to the highest grade, with minimal risk and 100 percent control.
This procurement is for the supply, implementation and support of a Warehouse Management System (WMS) for CGTC. The WMS solution will cover 2 sites, primarily the manufacturing centre in Stevenage with a subset of system functionality available for use at CGTC's Guys Hospital location. CGTC is committed to implementing an WMS system as a priority by May 2017 in time for the opening of the Manufacturing Centre in July 2017. Completion of formal GMP system qualification would be required to be completed no later than November 2017 in anticipation of inspection for licensure in December 2017.
The WMS solution will include product inventory, warehousing operations and stock control management as standard functionality along with associated supporting API interfaces.
The potential budget for the WMS system is between 300 000 GBP — 450 000 GBP total excluding VAT for the potential 5 year contract (3 years initially plus 2 further periods of up to 24 months).
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
450 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 60
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
To express an interest to received the tender documents you must provide your contact name, position in company, company name, address, email and mobile phone contact details to MCProcurement@ct.catapult.org.uk
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2016/S 109-194128
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
12/01/2017
Local time: 14:00
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 3 (from the date stated for receipt of tender)
IV.2.7) Conditions for opening of tenders
Date:
12/01/2017
Local time: 14:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.4) Procedures for review
VI.4.1) Review body
Cell and Gene Therapy Catapult
London
SE1 9RT
UK
VI.5) Date of dispatch of this notice
01/12/2016